The 2011 American Heart Association guidelines recommend open surgery or endovascular intervention to treat symptomatic ischemic lesions affecting the anterior cerebral circulation caused by Common carotid artery occlusion 1)
In March 2011, investigators from Australia and several other countries published the results of the DECRA trial in the New England Journal of Medicine. This was a randomized trial comparing decompressive craniectomy to best medical therapy run between 2002 and 2010 to assess the optimal management of patients with medically refractory ICP following diffuse non-penetrating head injury. The study investigators found that decompressive craniectomy was associated with worse functional outcomes, as measured by a standard metric, than best medical care. There were no differences in deaths between groups 2).
Cattle encephalon glycoside and ignotin injection (drug approval H22025046; Jilin Sihuan Pharmaceutical Co. LTD., Jilin, People’s Republic of China) was approved by the Chinese Food and Drug Administration in 2011.